MedTrace Logo

A Longitudinal Study of Amyotrophic Lateral Sclerosis (ALS) Biomarkers

NCT01495390 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 139

Last updated 2017-05-30

No results posted yet for this study

Summary

The purpose of this study is to collect biofluid samples for the banking and usage in ALS research. Through comparison of these samples, the researchers hope to learn more about the underlying cause of ALS, as well as find unique biological markers, which could be used to develop new therapies.

Conditions

Sponsors & Collaborators

  • ALS Association

    collaborator OTHER

  • ALS Finding a Cure

    collaborator OTHER

  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • James D. Berry, MD, MPH · Massachusetts General Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01495390 on ClinicalTrials.gov